• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

清除脑脊液中的细胞外α-突触核蛋白:帕金森病的一种新治疗策略。

Clearing Extracellular Alpha-Synuclein from Cerebrospinal Fluid: A New Therapeutic Strategy in Parkinson's Disease.

作者信息

Menéndez-González Manuel, Padilla-Zambrano Huber S, Tomás-Zapico Cristina, García Benjamin Fernández

机构信息

Servicio de Neurología, Hospital Universitario Central de Asturias, Oviedo 33011, Spain.

Department of Morphology and Cell Biology, University of Oviedo, Oviedo 33006, Spain.

出版信息

Brain Sci. 2018 Mar 23;8(4):52. doi: 10.3390/brainsci8040052.

DOI:10.3390/brainsci8040052
PMID:29570693
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5924388/
Abstract

This concept article aims to show the rationale of targeting extracellular α-Synuclein (α-Syn) from cerebrospinal fluid (CSF) as a new strategy to remove this protein from the brain in Parkinson's disease (PD). Misfolding and intracellular aggregation of α-synuclein into Lewy bodies are thought to be crucial in the pathogenesis of PD. Recent research has shown that small amounts of monomeric and oligomeric α-synuclein are released from neuronal cells by exocytosis and that this extracellular alpha-synuclein contributes to neurodegeneration, progressive spreading of alpha-synuclein pathology, and neuroinflammation. In PD, extracellular oligomeric-α-synuclein moves in constant equilibrium between the interstitial fluid (ISF) and the CSF. Thus, we expect that continuous depletion of oligomeric-α-synuclein in the CSF will produce a steady clearance of the protein in the ISF, preventing transmission and deposition in the brain.

摘要

这篇概念文章旨在阐述将脑脊液(CSF)中的细胞外α-突触核蛋白(α-Syn)作为从帕金森病(PD)大脑中清除该蛋白的新策略的基本原理。α-突触核蛋白错误折叠并在细胞内聚集成路易小体被认为在PD发病机制中起关键作用。最近的研究表明,少量的单体和寡聚α-突触核蛋白通过胞吐作用从神经元细胞释放出来,并且这种细胞外α-突触核蛋白会导致神经退行性变、α-突触核蛋白病理的进行性传播和神经炎症。在PD中,细胞外寡聚α-突触核蛋白在细胞间液(ISF)和脑脊液之间不断地处于平衡状态。因此,我们预计持续清除脑脊液中的寡聚α-突触核蛋白将使ISF中的该蛋白稳定清除,防止其在大脑中的传播和沉积。

相似文献

1
Clearing Extracellular Alpha-Synuclein from Cerebrospinal Fluid: A New Therapeutic Strategy in Parkinson's Disease.清除脑脊液中的细胞外α-突触核蛋白:帕金森病的一种新治疗策略。
Brain Sci. 2018 Mar 23;8(4):52. doi: 10.3390/brainsci8040052.
2
Induction of α-synuclein aggregate formation by CSF exosomes from patients with Parkinson's disease and dementia with Lewy bodies.帕金森病和路易体痴呆患者脑脊液来源外泌体诱导α-突触核蛋白聚集体形成
Brain. 2016 Feb;139(Pt 2):481-94. doi: 10.1093/brain/awv346. Epub 2015 Dec 8.
3
α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study.帕金森病患者脑脊液中α-突触核蛋白和tau 浓度:一项队列研究。
Lancet Neurol. 2011 Mar;10(3):230-40. doi: 10.1016/S1474-4422(11)70014-X.
4
Extracellular α--synuclein-a novel and crucial factor in Lewy body diseases.细胞外 α-突触核蛋白:路易体病的一个新的关键因素。
Nat Rev Neurol. 2014 Feb;10(2):92-8. doi: 10.1038/nrneurol.2013.275. Epub 2014 Jan 28.
5
New therapeutic approaches to target alpha-synuclein in Parkinson's disease: The role of immunotherapy.针对帕金森病中 alpha-synuclein 的新治疗方法:免疫疗法的作用。
Int Rev Neurobiol. 2019;146:281-295. doi: 10.1016/bs.irn.2019.06.014. Epub 2019 Jul 18.
6
Biological confounders for the values of cerebrospinal fluid proteins in Parkinson's disease and related disorders.帕金森病及相关疾病中脑脊液蛋白质值的生物学混杂因素。
J Neurochem. 2016 Oct;139 Suppl 1:290-317. doi: 10.1111/jnc.13390. Epub 2016 Feb 10.
7
Preclinical development of a high affinity α-synuclein antibody, MEDI1341, that can enter the brain, sequester extracellular α-synuclein and attenuate α-synuclein spreading in vivo.高亲和力α-突触核蛋白抗体 MEDI1341 的临床前开发,该抗体能够进入大脑,隔离细胞外α-突触核蛋白,并减轻体内α-突触核蛋白的扩散。
Neurobiol Dis. 2019 Dec;132:104582. doi: 10.1016/j.nbd.2019.104582. Epub 2019 Aug 21.
8
Parkinson's and Lewy body dementia CSF biomarkers.帕金森病和路易体痴呆的脑脊液生物标志物。
Clin Chim Acta. 2019 Aug;495:318-325. doi: 10.1016/j.cca.2019.04.078. Epub 2019 Apr 30.
9
Detection of oligomeric forms of alpha-synuclein protein in human plasma as a potential biomarker for Parkinson's disease.检测人血浆中α-突触核蛋白的寡聚体形式作为帕金森病的潜在生物标志物。
FASEB J. 2006 Mar;20(3):419-25. doi: 10.1096/fj.03-1449com.
10
Correlates of cerebrospinal fluid levels of oligomeric- and total-α-synuclein in premotor, motor and dementia stages of Parkinson's disease.帕金森病前驱期、运动期和痴呆期脑脊液寡聚和总α-突触核蛋白水平的相关性。
J Neurol. 2015 Feb;262(2):294-306. doi: 10.1007/s00415-014-7560-z. Epub 2014 Nov 8.

引用本文的文献

1
Restoring autophagic function: a case for type 2 diabetes mellitus drug repurposing in Parkinson's disease.恢复自噬功能:2型糖尿病药物在帕金森病中的重新利用案例。
Front Neurosci. 2023 Nov 3;17:1244022. doi: 10.3389/fnins.2023.1244022. eCollection 2023.
2
Intrathecal Pseudodelivery of Drugs in the Therapy of Neurodegenerative Diseases: Rationale, Basis and Potential Applications.鞘内假性给药在神经退行性疾病治疗中的应用:原理、基础及潜在应用
Pharmaceutics. 2023 Feb 25;15(3):768. doi: 10.3390/pharmaceutics15030768.
3
The "Cerebrospinal Fluid Sink Therapeutic Strategy" in Alzheimer's Disease-From Theory to Design of Applied Systems.

本文引用的文献

1
Mechanisms of α-Synuclein Induced Synaptopathy in Parkinson's Disease.帕金森病中α-突触核蛋白诱导突触病变的机制
Front Neurosci. 2018 Feb 19;12:80. doi: 10.3389/fnins.2018.00080. eCollection 2018.
2
Mechanical Dilution of Beta-amyloid Peptide and Phosphorylated Tau Protein in Alzheimer's Disease: Too Simple to be True?阿尔茨海默病中β-淀粉样肽和磷酸化tau蛋白的机械稀释:是否过于简单而不真实?
Cureus. 2017 Feb 28;9(2):e1062. doi: 10.7759/cureus.1062.
3
Alpha-synuclein structure, functions, and interactions.α-突触核蛋白的结构、功能及相互作用。
阿尔茨海默病中的“脑脊液汇治疗策略”——从理论到应用系统设计
Biomedicines. 2022 Jun 25;10(7):1509. doi: 10.3390/biomedicines10071509.
4
Challenges in Discovering Drugs That Target the Protein-Protein Interactions of Disordered Proteins.发现靶向无序蛋白质的蛋白质-蛋白质相互作用药物的挑战。
Int J Mol Sci. 2022 Jan 28;23(3):1550. doi: 10.3390/ijms23031550.
5
Alpha-Synuclein PET Tracer Development-An Overview about Current Efforts.α-突触核蛋白正电子发射断层显像示踪剂的研发——当前研究进展概述
Pharmaceuticals (Basel). 2021 Aug 26;14(9):847. doi: 10.3390/ph14090847.
6
Co-Transmission of Alpha-Synuclein and TPPP/p25 Inhibits Their Proteolytic Degradation in Human Cell Models.α-突触核蛋白与TPPP/p25的共传递抑制其在人类细胞模型中的蛋白水解降解。
Front Mol Biosci. 2021 May 18;8:666026. doi: 10.3389/fmolb.2021.666026. eCollection 2021.
7
Glucuronomannan GM2 from Enhanced Mitochondrial Function and Autophagy in a Parkinson's Model.来自帕金森病模型中增强线粒体功能和自噬的葡糖醛酸甘露聚糖GM2。
Mar Drugs. 2021 Jan 25;19(2):58. doi: 10.3390/md19020058.
8
Plasma and Serum Alpha-Synuclein as a Biomarker of Diagnosis in Patients With Parkinson's Disease.血浆和血清α-突触核蛋白作为帕金森病患者诊断的生物标志物
Front Neurol. 2020 Jan 21;10:1388. doi: 10.3389/fneur.2019.01388. eCollection 2019.
9
Baseline concentration of misfolded α-synuclein aggregates in cerebrospinal fluid predicts risk of cognitive decline in Parkinson's disease.脑脊液中错误折叠的α-突触核蛋白聚集体的基线浓度可预测帕金森病患者认知能力下降的风险。
Neuropathol Appl Neurobiol. 2019 Jun;45(4):398-409. doi: 10.1111/nan.12524. Epub 2018 Nov 15.
10
α-Synuclein disrupts the anti-inflammatory role of Drd2 via interfering β-arrestin2-TAB1 interaction in astrocytes.α-突触核蛋白通过干扰星形胶质细胞中β-arrestin2-TAB1 相互作用破坏 Drd2 的抗炎作用。
J Neuroinflammation. 2018 Sep 10;15(1):258. doi: 10.1186/s12974-018-1302-6.
J Res Med Sci. 2016 May 9;21:29. doi: 10.4103/1735-1995.181989. eCollection 2016.
4
Alpha-Synuclein in Parkinson's Disease: From Pathogenetic Dysfunction to Potential Clinical Application.帕金森病中的α-突触核蛋白:从致病性功能障碍到潜在临床应用
Parkinsons Dis. 2016;2016:1720621. doi: 10.1155/2016/1720621. Epub 2016 Aug 17.
5
Targeting α-synuclein: Therapeutic options.靶向α-突触核蛋白:治疗选择。
Mov Disord. 2016 Jun;31(6):882-8. doi: 10.1002/mds.26568. Epub 2016 Mar 1.
6
Dynamic structural flexibility of α-synuclein.α-突触核蛋白的动态结构灵活性
Neurobiol Dis. 2016 Apr;88:66-74. doi: 10.1016/j.nbd.2015.12.018. Epub 2015 Dec 31.
7
Effects of Serine 129 Phosphorylation on α-Synuclein Aggregation, Membrane Association, and Internalization.丝氨酸129磷酸化对α-突触核蛋白聚集、膜结合及内化的影响
J Biol Chem. 2016 Feb 26;291(9):4374-85. doi: 10.1074/jbc.M115.705095. Epub 2015 Dec 30.
8
Alpha-synuclein Toxicity in the Early Secretory Pathway: How It Drives Neurodegeneration in Parkinsons Disease.早期分泌途径中的α-突触核蛋白毒性:其如何引发帕金森病中的神经退行性变
Front Neurosci. 2015 Nov 12;9:433. doi: 10.3389/fnins.2015.00433. eCollection 2015.
9
Gastrointestinal Biopsies for the Diagnosis of Alpha-Synuclein Pathology in Parkinson's Disease.用于帕金森病中α-突触核蛋白病理诊断的胃肠道活检
Gastroenterol Res Pract. 2015;2015:476041. doi: 10.1155/2015/476041. Epub 2015 May 11.
10
Autophagy in neurodegenerative diseases: From pathogenic dysfunction to therapeutic modulation.神经退行性疾病中的自噬:从致病功能障碍到治疗调节。
Semin Cell Dev Biol. 2015 Apr;40:115-26. doi: 10.1016/j.semcdb.2015.03.005. Epub 2015 Apr 2.